Lenalidomide and Rituximab as Treatment of Chronic Lymphocytic Leukemia
Status:
Completed
Trial end date:
2014-07-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to learn if the combination of lenalidomide and
rituximab can help to control Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic
Lymphoma (SLL) in patients who have already received therapy. The safety of this drug
combination will also be studied.